Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?
- PMID: 8536271
- PMCID: PMC11037825
- DOI: 10.1007/BF01517213
Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?
References
-
- Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo MP, Dellabona P, Hock H, Blankenstein T, Rosenthal FM, Gansbacher B, Colombo MC, Musso T, Gusella L, Forni G. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL-2, IL-4, IL-6, IL-7, IL-10, TNFα, GM-CSF, and IFNγ gene or admixed with conventional adjuvants. Cancer Res. 1994;54:6022. - PubMed
-
- Boel P, Wildman C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, Van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 1995;2:167. - PubMed
-
- Boon T, Cerottini JC, Van den Eynde B, Van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical